Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Gilead Sciences (NQ: GILD )

58.15 USD -0.38 (-0.65%)
Official Closing Price Updated: 7:59 PM EDT, Oct 30, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,871,600
Open 57.79
Bid (Size) 58.00 (4)
Ask (Size) 58.09 (2)
Prev. Close 58.53
Today's Range 57.18 - 58.58
52wk Range 57.04 - 85.97
Shares Outstanding 1,300,260,832
Dividend Yield 3.83%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Gilead Sciences Announces Fourth Quarter 2020 Dividend
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared a cash dividend of $0.68 per share of common stock for the fourth quarter of 2020. The dividend... 
From Business Wire News Releases
Gilead Sciences Announces Third Quarter 2020 Financial Results
Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the third quarter 2020. 
From Business Wire News Releases

Performance

YTD
-10.85%
-10.85%
1 Month
-7.98%
-7.98%
3 Month
-16.37%
-16.37%
6 Month
-27.27%
-27.27%
1 Year
-8.73%
-8.73%

More News

Read More
10 Biggest Price Target Changes For Thursday
Tags EBAY CCXI Benzinga
From Benzinga
Gilead unexpectedly cashes in with nearly $900 million in sales of COVID-19 drug
Tags Earnings GILD Pharmaceuticals
From MarketWatch
Gilead Sees Underwhelming Demand For FDA-Approved COVID-19 Drug Remdesivir
Tags Covid/19 General GILD
From Benzinga
Stock futures rise ahead of GDP data after worst day since June
Tags COMP TPR YM00
From MarketWatch
Recap: Gilead Sciences Q3 Earnings
Tags Earnings GILD Market News
From Benzinga
Gilead’s Remdesivir Brought In $873 Million During The Third Quarter
Tags Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
Gilead Sciences Posts Earnings Beat But Lowers Outlook, After GILD Stock Hits Seven-Year Lows
From Investor's Business Daily
Fast start for coronavirus drug boosts Gilead earnings, sends stock higher in late trading
Tags SPX GILD
From MarketWatch
Cramer Shares His Thoughts On Slack, Gilead And More
Tags KMB PG GILD
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.